Zelira Therapeutics (ZLDAF)
OTHER OTC:ZLDAF
Holding ZLDAF?
Track your performance easily

Zelira Therapeutics (ZLDAF) Income Statement

16 Followers

Zelira Therapeutics Income Statement

Last quarter (Q4 2022), Zelira Therapeutics's total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Zelira Therapeutics's net income was AU$―. See Zelira Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20Jun 19Jun 18
Total Revenue
-AU$ 1.54MAU$ 432.57K---
Cost of Revenue
-AU$ 939.05KAU$ 228.22K---
Gross Profit
-AU$ 601.57KAU$ 204.35K---
Operating Expense
-AU$ 14.25MAU$ 10.20MAU$ 7.94MAU$ 4.24MAU$ 2.83M
Operating Income
-AU$ -13.65MAU$ -9.99MAU$ -7.94MAU$ -4.24MAU$ -2.83M
Net Non Operating Interest Income Expense
-AU$ -43.25KAU$ -41.90KAU$ -3.74KAU$ 90.14KAU$ 138.57K
Other Income Expense
-AU$ 1.28MAU$ 1.48MAU$ 925.49KAU$ 580.44KAU$ 959.82K
Pretax Income
-AU$ -12.41MAU$ -8.55MAU$ -7.02MAU$ -3.57MAU$ -1.73M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-AU$ -11.95MAU$ -8.55MAU$ -7.02MAU$ -3.57MAU$ -1.73M
Basic EPS
-AU$ -1.54AU$ -1.28AU$ -1.45AU$ >-0.01AU$ >-0.01
Diluted EPS
-AU$ -1.54AU$ -1.28AU$ -1.45AU$ >-0.01AU$ >-0.01
Basic Average Shares
-AU$ 8.04MAU$ 6.63MAU$ 4.85MAU$ 755.07MAU$ 755.07M
Diluted Average Shares
-AU$ 8.04MAU$ 6.63MAU$ 4.85MAU$ 755.07MAU$ 755.07M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
------
Net Income From Continuing And Discontinued Operation
-AU$ -11.95MAU$ -8.55MAU$ -7.02MAU$ -3.57MAU$ -1.73M
Normalized Income
-AU$ -11.95MAU$ -8.55MAU$ -7.02MAU$ -3.57MAU$ -1.73M
Interest Expense
-AU$ 53.85KAU$ 42.63KAU$ 12.34K--
EBIT
-AU$ -12.36MAU$ -8.51MAU$ -7.00MAU$ -4.24MAU$ -2.83M
EBITDA
-AU$ -11.77MAU$ -8.03MAU$ -6.73MAU$ -4.24MAU$ -2.83M
Currency in AUD

Zelira Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis